Kang‐Yin Chen

938 total citations
52 papers, 392 citations indexed

About

Kang‐Yin Chen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Kang‐Yin Chen has authored 52 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Kang‐Yin Chen's work include Coronary Interventions and Diagnostics (11 papers), Acute Myocardial Infarction Research (10 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Kang‐Yin Chen is often cited by papers focused on Coronary Interventions and Diagnostics (11 papers), Acute Myocardial Infarction Research (10 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Kang‐Yin Chen collaborates with scholars based in China, South Korea and United States. Kang‐Yin Chen's co-authors include Tong Liu, Guangping Li, Seung‐Woon Rha, Qingmiao Shao, Hong Euy Lim, Umesh Tamhane, Michael Grossman, Pascal Meier, Stanley Chetcuti and Hitinder S. Gurm and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Kang‐Yin Chen

41 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kang‐Yin Chen China 9 202 85 83 49 44 52 392
Mélanie Gaubert France 10 133 0.7× 67 0.8× 81 1.0× 68 1.4× 32 0.7× 20 348
Sumit Kunwar United States 6 203 1.0× 33 0.4× 66 0.8× 23 0.5× 22 0.5× 7 416
Urszula Zurawska Canada 7 234 1.2× 121 1.4× 68 0.8× 63 1.3× 14 0.3× 12 480
Kavita Shalia India 10 127 0.6× 57 0.7× 74 0.9× 31 0.6× 22 0.5× 32 334
Roza Badr Eslam Austria 13 188 0.9× 198 2.3× 69 0.8× 45 0.9× 27 0.6× 49 421
Frans Beerkens United States 10 256 1.3× 158 1.9× 167 2.0× 31 0.6× 12 0.3× 29 563
Shmuel Schwartzenberg Israel 13 423 2.1× 117 1.4× 103 1.2× 47 1.0× 13 0.3× 34 612
Monica Ahuja India 12 239 1.2× 99 1.2× 71 0.9× 36 0.7× 6 0.1× 16 547
Tomoya Hara Japan 9 176 0.9× 35 0.4× 68 0.8× 7 0.1× 27 0.6× 21 364

Countries citing papers authored by Kang‐Yin Chen

Since Specialization
Citations

This map shows the geographic impact of Kang‐Yin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang‐Yin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang‐Yin Chen more than expected).

Fields of papers citing papers by Kang‐Yin Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kang‐Yin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang‐Yin Chen. The network helps show where Kang‐Yin Chen may publish in the future.

Co-authorship network of co-authors of Kang‐Yin Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Kang‐Yin Chen. A scholar is included among the top collaborators of Kang‐Yin Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kang‐Yin Chen. Kang‐Yin Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Ying, Hong‐Min Liu, Gary Tse, et al.. (2025). Association of Estimated Glomerular Filtration Rate (eGFR) and High-Sensitivity C-Reactive Protein (Hs-CRP) with the Risk of New-Onset Atrial Fibrillation in Patients with Diabetes. Journal of Inflammation Research. Volume 18. 91–103. 2 indexed citations
3.
Chen, Kang‐Yin, et al.. (2025). The prognostic value of the index of angiography-derived microcirculatory resistance in patients with STEMI. Journal of Cardiovascular Medicine. 26(11). 627–637.
4.
Zhao, Liming, Jiamei Liu, Yin Liu, et al.. (2025). LDL-C Reduction with Evolocumab Among Patients with ASCVD in China: Real-World Evidence from Tianjin Metropolitan Area. Advances in Therapy. 42(6). 2874–2887.
5.
Gao, Wenqing, et al.. (2024). Microcirculatory dysfunction in hypertrophic cardiomyopathy with chest pain assessed by angiography-derived microcirculatory resistance. Scientific Reports. 14(1). 16977–16977. 1 indexed citations
6.
7.
Zhang, Nan, et al.. (2024). PCSK9 inhibitor with cause-specific mortality amongst cancer survivors: a chance to kill two birds with one stone. European Journal of Preventive Cardiology. 33(4). 612–614. 1 indexed citations
8.
9.
Liu, Tong, Yukun Zhang, Peng Wang, et al.. (2024). Prevalence, clinical characteristics, and long-term outcomes of new diabetes diagnosis in elderly patients undergoing percutaneous coronary intervention. Scientific Reports. 14(1). 14814–14814. 2 indexed citations
10.
Wang, Weiding, Changle Liu, Juan Xie, et al.. (2023). Combination of SVI/S′ and diagnostic scores for heart failure with preserved ejection fraction. Clinical and Experimental Pharmacology and Physiology. 50(8). 677–687. 3 indexed citations
11.
Zhang, Hao, Tong Liu, & Kang‐Yin Chen. (2023). Easily Neglected Manifestations in Electrocardiogram in the Prone Position. JAMA Internal Medicine. 183(8). 871–871.
12.
13.
14.
Sun, Guijiang, Xiaomeng Li, Jinxia Wei, et al.. (2021). Pharmacodynamic substances in Salvia miltiorrhiza for prevention and treatment of hyperlipidemia and coronary heart disease based on lipidomics technology and network pharmacology analysis. Biomedicine & Pharmacotherapy. 141. 111846–111846. 35 indexed citations
15.
Zhang, Zhiyan, Heyang Sun, Kang‐Yin Chen, et al.. (2020). Temporal lung changes on thin-section CT in patients with COVID-19 pneumonia. Scientific Reports. 10(1). 5 indexed citations
16.
Zhang, Nixiao, et al.. (2016). Another side effect of ticagrelor: Atrial fibrillation. International Journal of Cardiology. 212. 242–244. 7 indexed citations
17.
Xu, Lingxia, et al.. (2016). GW27-e0058 Comparisons of loading doses of ticagrelor versus clopidogrel in preventing periprocedural myocardial infarction. Journal of the American College of Cardiology. 68(16). C89–C90. 1 indexed citations
18.
Shao, Qingmiao, Kang‐Yin Chen, Seung‐Woon Rha, et al.. (2015). Usefulness of Neutrophil/Lymphocyte Ratio as a Predictor of Atrial Fibrillation: A Meta-analysis. Archives of Medical Research. 46(3). 199–206. 95 indexed citations
19.
Zhao, Zhiqiang, Xinghua Wang, Jian Li, et al.. (2014). Protective Effects of Aliskiren on Atrial Ionic Remodeling in a Canine Model of Rapid Atrial Pacing. Cardiovascular Drugs and Therapy. 28(2). 137–143. 5 indexed citations
20.
Li, Guangping, Weiding Wang, Qiang Li, et al.. (2011). Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score.. PubMed. 18(4). 364–70. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mélanie Gaubert Breakdown of academic impact, for papers by Sumit Kunwar Breakdown of academic impact, for papers by Urszula Zurawska Breakdown of academic impact, for papers by Kavita Shalia Breakdown of academic impact, for papers by Roza Badr Eslam Breakdown of academic impact, for papers by Frans Beerkens Breakdown of academic impact, for papers by Shmuel Schwartzenberg Breakdown of academic impact, for papers by Monica Ahuja Breakdown of academic impact, for papers by Tomoya Hara
Rankless by CCL
2026